Apeiron Capital LTD Moderna, Inc. Transaction History

Apeiron Capital LTD

  • $137 Million
  • Q3 2024

A detailed history of Apeiron Capital LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Apeiron Capital LTD holds 27,115 shares of MRNA stock, worth $999,187. This represents 1.32% of its overall portfolio holdings.

Number of Shares
27,115
Previous 27,115 -0.0%
Holding current value
$999,187
Previous $3.22 Million 43.71%
% of portfolio
1.32%
Previous 2.79%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$101.21 - $166.61 $2.03 Million - $3.34 Million
20,046 Added 283.58%
27,115 $3.22 Million
Q1 2024

Apr 11, 2024
SELL
$85.37 - $115.44 $2.06 Million - $2.79 Million
-24,131 Reduced 77.34%
7,069 $753,000
Q4 2023

Jan 31, 2024
BUY
$69.51 - $104.43 $1.06 Million - $1.6 Million
15,300 Added 96.23%
31,200 $3.1 Million
Q2 2023

Jul 24, 2023
SELL
$118.5 - $160.53 $841,350 - $1.14 Million
-7,100 Reduced 30.87%
15,900 $1.93 Million
Q1 2023

Apr 24, 2023
BUY
$135.66 - $197.02 $3.12 Million - $4.53 Million
23,000 New
23,000 $3.53 Million
Q4 2021

Jan 26, 2022
BUY
$225.82 - $368.51 $700,042 - $1.14 Million
3,100 Added 3.53%
91,000 $23.1 Million
Q3 2021

Oct 29, 2021
BUY
$221.9 - $484.47 $1.31 Million - $2.86 Million
5,900 Added 7.2%
87,900 $33.8 Million
Q2 2021

Jul 14, 2021
BUY
$129.91 - $234.98 $6.11 Million - $11 Million
47,000 Added 134.29%
82,000 $19.3 Million
Q1 2021

Apr 12, 2021
BUY
$109.18 - $185.98 $3.82 Million - $6.51 Million
35,000 New
35,000 $4.58 Million

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Apeiron Capital LTD Portfolio

Follow Apeiron Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apeiron Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Apeiron Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email